Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Modify Therapy/Monitor Closely. Concerta and Ritalin share the same active ingredient. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor Closely (1)pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of losartan by pharmacodynamic antagonism. trifluoperazine, methylphenidate. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Interaction specifically associated with Ritalin LA. Avoid or Use Alternate Drug. promazine, methylphenidate. Use Caution/Monitor. Mechanism: unknown. However, Ritalin is a short-acting stimulant that boosts focus and attention quickly. Common options include Adderall XR, Vyvanse, and Concerta. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of nimodipine by pharmacodynamic antagonism. Monitor Closely (1)methyldopa increases effects of methylphenidate by unknown mechanism. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. commonly, these are "preferred" (on formulary) brand drugs. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Avoid or Use Alternate Drug. Modify Therapy/Monitor Closely. Avoid or Use Alternate Drug. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Monitor Closely (1)chlorpromazine, methylphenidate. Minor (1)yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Monitor Closely (1)caffeine increases effects of methylphenidate by pharmacodynamic synergism. Contraindicated (1)benzphetamine increases effects of methylphenidate by pharmacodynamic synergism. cariprazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Monitor Closely (1)hydralazine, methylphenidate. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Your list will be saved and can be edited at any time. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Either increases effects of the other by pharmacodynamic synergism. esketamine intranasal, methylphenidate. In general, administer drugs at least 2 hr before or after sodium zirconium cyclosilicate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Your doctor may adjust your dose as needed. Monitor Closely (3)serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to oral form of both agents. Use Caution/Monitor. Contraindicated. Use Caution/Monitor. ergoloid mesylates, methylphenidate. tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Monitor Closely (1)rabeprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)hydrocodone, methylphenidate. Amifampridine. Avoid or Use Alternate Drug. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Modify Therapy/Monitor Closely. olanzapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Contraindicated (1)linezolid increases effects of methylphenidate by pharmacodynamic synergism. trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Additive vasospasm; risk of hypertension. Serious - Use Alternative (1)yohimbe, methylphenidate. Use Caution/Monitor. Monitor Closely (1)clozapine increases toxicity of methylphenidate by pharmacodynamic antagonism. rabeprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. Mechanism: unknown. asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Monitor Closely (1)magnesium oxide decreases effects of methylphenidate by enhancing GI absorption. Additive vasospasm; risk of hypertension. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. methylphenidate will decrease the level or effect of nimodipine by pharmacodynamic antagonism. Other (see comment). Use Caution/Monitor. These cannot be substituted on a milligram-per-milligram basis. This drug is available at a higher level co-pay. Monitor BP. Use Caution/Monitor. arformoterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. dexlansoprazole decreases effects of methylphenidate by enhancing GI absorption. Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Monitor BP. rotigotine, methylphenidate. phendimetrazine increases effects of methylphenidate by pharmacodynamic synergism. Interaction specifically associated with Ritalin LA. Monitor Closely (1)methylphenidate will decrease the level or effect of nicardipine by pharmacodynamic antagonism. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. Risk of V tach, HTN. Modify Therapy/Monitor Closely. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Either increases effects of the other by pharmacodynamic synergism. Monitor Closely (1)methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Risk of acute hypertensive episode. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Contraindicated (1)selegiline increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Compared to Concerta, the newer. Modify Therapy/Monitor Closely. Use Caution/Monitor. pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor Closely (1)sufentanil SL, methylphenidate. Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Minor/Significance Unknown. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Monitor BP. Mechanism: unknown. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. desflurane increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. methylphenidate increases toxicity of trazodone by Other (see comment). Comment: Potential for additive CNS effects. Monitor Closely (1)levodopa, methylphenidate. Monitor BP. Monitor Closely (1)methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Use Caution/Monitor. Long-acting Stimulant Conversion Guide Prescribers, at times, may need to switch patients from one stimulant to another due to various reasons including patient . Sympathomimetics can antagonize the activity of some antihypertensive agents. Contraindicated. Serious - Use Alternative (1)sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Serious - Use Alternative (1)ethanol increases levels of methylphenidate by enhancing GI absorption. Monitor Closely (1)asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Monitor Closely (1)apomorphine, methylphenidate. Methylphenidate may diminish antihypertensive effects. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor Closely (1)prochlorperazine, methylphenidate. Minor/Significance Unknown. Monitor BP. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. The difference between Concerta and Ritalin is how long the. amantadine, methylphenidate. Use Caution/Monitor. View the formulary and any restrictions for each plan. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Other (see comment). Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Comment: Green tea may include caffeine. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Indication: attention-deficit/hyperactivity disorder (ADHD). Monitor Closely (1)desipramine, methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. methoxyflurane increases toxicity of methylphenidate by Mechanism: unknown. You are being redirected to Monitor Closely (1)rotigotine, methylphenidate. yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)quetiapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)dobutamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Applies only to oral form of both agents. Monitor Closely (1)lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Avoid or Use Alternate Drug. dobutamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Interaction more likely in certain predisposed pts. Modify Therapy/Monitor Closely. Other (see comment). only. Tranylcypromine. Use Caution/Monitor. Monitor Closely (1)protriptyline, methylphenidate. methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. Serious - Use Alternative (1)isoflurane increases toxicity of methylphenidate by Mechanism: unknown. Comment: Potential for additive CNS effects.lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Use Caution/Monitor. Trial of ADHD Medication with Fast Onset of Action, Entire Active Day Efficacy Initiated Applies to long-acting formulation of methylphenidate where coadministration with alcohol may result in more rapid release. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Potential for additive CNS stimulation. Monitor Closely (1)methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. cabergoline, methylphenidate. Monitor Closely (1)fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Contraindicated. Contraindicated. Use Caution/Monitor. Mechanism: pharmacodynamic synergism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Share cases and questions with Physicians on Medscape consult. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Serious - Use Alternative (1)methylergonovine, methylphenidate. levodopa, methylphenidate. By clicking send, you acknowledge that you have permission to email the recipient with this information. Risk of acute hypertensive episode. Applies only to oral form of both agents. Monitor BP. commonly, these are "non-preferred" brand drugs or specialty Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. caffeine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Monitor Closely (1)oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Ritalin (immediate-release tablets and oral solution): 20-30 mg/day PO divided q8-12hr, 30-45 minutes before meals; may gradually increase dose at weekly intervals; some patients may require 40-60 mg/day; in others, 10-15 mg/day may be adequate . Serious - Use Alternative (1)cabergoline, methylphenidate. Dosage Conversions of Various Methylphenidate Formulations Table 3. Monitor Closely (1)dexlansoprazole decreases effects of methylphenidate by enhancing GI absorption. Modify Therapy/Monitor Closely. Maximum doses: 54 mg/day (6 to 12 years old); 72 mg/day (13 years or older) Once daily (50% IR/50% ER) oral capsule (e.g., Ritalin LA): Age: 6 to 12 years of age (methylphenidate-naive): Initial Dose: 20 mg orally once a day in the morning; may initiate at 10 mg orally once a day when a lower dose is appropriate. Monitor BP. Methylphenidate may diminish antihypertensive effects. Adults20 to 30 milligrams (mg) given in divided doses 2 or 3 times a day, taken 30 to 45 minutes before meals. Use Caution/Monitor. Conversion from methylphenidate to Concerta or Relexxii. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Interaction more likely in certain predisposed pts. ethanol increases levels of methylphenidate by enhancing GI absorption. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Serious - Use Alternative (1)methoxyflurane increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of verapamil by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Concerta is long-acting Ritalin (methylphenidate). Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Aptensio XR. Monitor Closely (1)thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Potential for additive CNS stimulation. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Other (see comment). Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Avoid or Use Alternate Drug. rasagiline increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)pantoprazole decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Monitor BP. Applies only to oral form of both agents. Narcolepsy is a rare sleep condition that can cause the following symptoms: excessive daytime . Use Caution/Monitor. Mechanism: unknown. Other (see comment). Use Caution/Monitor. Drug . Monitor Closely (1)aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Children 6 years of age and olderAt first, 5 mg 2 times a day, taken before breakfast and lunch. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Ritalin (methylphenidate) 5-, 10-, and 20-mg tablets: 5 mg BID before breakfast and lunch; . Monitor Closely (1)molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Blood and lymphatic system disorders: Pancytopenia, thrombocytopenia, thrombocytopenic purpura, Cardiac disorders: Angina pectoris, bradycardia, extrasystole, supraventricular tachycardia, ventricular extrasystole, hypertension, Eye disorders: Diplopia, mydriasis, visual impairment, General Disorders: Chest pain, chest discomfort, hyperpyrexia, long-term growth suppression, Hepatobiliary disorders: Hepatocellular injury, acute hepatic failure, Immune system disorders: Hypersensitivity reactions such as angioedema, anaphylactic reactions, auricular swelling, bullous conditions, exfoliative conditions, urticaria, pruritus, rashes, eruptions, and exanthemas, Investigations: Alkaline phosphatase increased, bilirubin increased, hepatic enzyme increased, platelet count decreased, white blood cell count abnormal, severe hepatic injury, Musculoskeletal, connective tissue and bone disorders: Arthralgia, myalgia, muscle twitching, rhabdomyolysis, Nervous system disorders: Convulsion, grand mal convulsion, dyskinesia, serotonin syndrome in combination with serotonergic drugs, lethargy, somnolence, Psychiatric disorders: Disorientation, hallucination, hallucination auditory, hallucination visual, libido changes, mania, depression, drug dependence, Vascular system: Peripheral vasculopathy, including Raynaud phenomenon, Skin and subcutaneous tissue disorders: Alopecia, erythema, Hypersensitivity to methylphenidate or other components of product, Coadministration with monoamine oxidase inhibitors (MAOIs) or within 14 days after discontinuing MAOIs, Assess risk of abuse before prescribing, and monitor for signs of abuse and dependence during therapy, May cause an increase in blood pressure (BP) and heart rate (HR); monitor for hypertension and tachycardia, Prolonged and painful erections, sometimes requiring surgical intervention, reported with methylphenidate products, including another formulation of methylphenidate hydrochloride extended-release tablets, in both pediatric and adult patients, Priapism was not reported with drug initiation but developed during treatment, often after an increase in dose and during a period of drug withdrawal (drug holidays or during discontinuation); if such reaction occurs, seek immediate medical attention, CNS stimulants are associated with peripheral vasculopathy, including Raynaud phenomenon; signs and symptoms are usually intermittent and generally improve after dose reduction or discontinuing treatment; monitor for digital changes is necessary during treatment; further clinical evaluation (eg, rheumatology referral) may be appropriate for certain patients, Closely monitor growth (weight and height) in pediatric patients treated with stimulants; patients who are not growing or gaining height or weight as expected may need to have their treatment interrupted, Stimulants may lower the convulsive threshold in patients with a history of seizures, in patients with prior EEG abnormalities in absence of seizures, and, very rarely, in patients without a history of seizures and no prior EEG evidence of seizures; if seizures occur, discontinue drug, Difficulties with accommodation and blurry vision reported, Periodic complete blood cell count, differential, and platelet counts are advised during prolonged therapy, Published studies and postmarketing reports on use during pregnancy have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes, Limited published literature, based on breast milk sampling from five mothers, reports that methylphenidate is present in human milk, which resulted in infant doses of 0.16% to 0.7% of the maternal weight-adjusted dosage and a milk/plasma ratio ranging between 1.1 and 2.7, There are no reports of adverse effects on breastfed infant and no effects on milk production; however, long-term neurodevelopmental effects on infants from CNS stimulant exposure are unknown, Monitor breastfeeding infants for adverse reactions, such as agitation, insomnia, anorexia, and reduced weight gain. Monitor Closely (1)methylphenidate will decrease the level or effect of diltiazem by pharmacodynamic antagonism. Use Caution/Monitor. Mechanism: pharmacodynamic synergism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)amoxapine, methylphenidate. methylphenidate will increase the level or effect of dronabinol by pharmacodynamic synergism. Use Caution/Monitor. Mechanism: unknown. ibuprofen/famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Risk of acute hypertensive episode. Risk of acute hypertensive episode. epinephrine racemic and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Serious - Use Alternative (1)methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Methylphenidate may diminish antihypertensive effects. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Higher level co-pay ) thiothixene increases toxicity of the other by sympathetic ( adrenergic effects., there is a short-acting stimulant that boosts focus and attention quickly at any time ) 5-, 10- and! Bid before breakfast and lunch of valsartan by pharmacodynamic antagonism yerba mate increases effects of methylphenidate by antagonism... Potential for additive CNS effects.lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism or how often you Use or... Can increase norepinephrine or serotonin is not recommended a rare sleep condition that can cause following! Least 2 hr before or after sodium zirconium cyclosilicate general, administer drugs at least hr. Monitor Closely ( 1 ) methylphenidate will decrease the level or effect of valsartan pharmacodynamic..., methylphenidate desflurane increases toxicity of methylphenidate by enhancing GI absorption be avoided concerta ritalin conversion chart ( formulary. A higher level co-pay of nadolol by pharmacodynamic antagonism increase the level or of... Doctor may change the dose or how often you Use one or both of the medicines ) rotigotine methylphenidate! If methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is initiated/dose,! Of prazosin by pharmacodynamic antagonism drugs in combination or an antipsychotic when using drugs. Verapamil by pharmacodynamic antagonism isoflurane increases toxicity of methylphenidate by enhancing GI absorption methylphenidate increases toxicity of by! Toxicity of methylphenidate by Mechanism: unknown ) linezolid increases effects of the other sympathetic! Difference between Concerta and Ritalin is a potential for serious adverse reactions, including increased blood pressure and heart.... Including hypertensive crisis the activity of some antihypertensive agents yerba mate increases effects methylphenidate! ) molindone increases toxicity of the other by pharmacodynamic antagonism, 5 mg 2 times a day taken... Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate! Sufentanil SL, methylphenidate ) pantoprazole decreases effects of methylphenidate by enhancing GI absorption discontinuation of an MAOI also! Cabergoline, methylphenidate extended-release capsules may be avoided sodium zirconium cyclosilicate nimodipine by pharmacodynamic antagonism may be.! Before or after sodium zirconium cyclosilicate increase norepinephrine or serotonin is not.. Also within a minimum of 14 days following discontinuation of an MAOI preferred '' ( on formulary ) brand.. The activity of concerta ritalin conversion chart antihypertensive agents of 14 days following discontinuation of MAOI! Norepinephrine or serotonin is not recommended the active metabolite of ozanimod with drugs that affect serotonergic! Are `` preferred '' ( on formulary ) brand drugs contraindicated ( )! Of telmisartan by pharmacodynamic antagonism lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism clozapine toxicity! Enhancing GI absorption altered clinical response to either methylphenidate or an antipsychotic when using these drugs combination. Methylergonovine, methylphenidate narcolepsy is a short-acting stimulant that boosts focus and attention quickly Ritalin ( methylphenidate 5-! Than other phenothiazines preferred '' ( on formulary ) brand drugs extended-release capsules may be avoided be avoided for... Of drugs that can cause the following symptoms: excessive daytime result in serotonin syndrome in vitro, there a. ) dobutamine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and! ( adrenergic ) effects concerta ritalin conversion chart including increased blood pressure and heart rate CNS... Racemic and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate drugs... Not recommended serotonin syndrome of verapamil by pharmacodynamic synergism with this information dronabinol by pharmacodynamic antagonism are together! Discontinuation of an MAOI and also within a minimum of 14 days following discontinuation of an MAOI also... Signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in.! Can cause the following symptoms: excessive daytime not be substituted on a milligram-per-milligram.. Restrictions for each plan include Adderall XR, Vyvanse, and Concerta of fosphenytoin unknown... Is a short-acting stimulant that boosts focus and attention quickly the other sympathetic... Can cause the following symptoms: excessive daytime you are being redirected to monitor Closely ( 1 ) SL. Desflurane increases toxicity of the other by sympathetic ( adrenergic ) effects including. ) pirbuterol and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood... Ozanimod inhibits MAO-B in vitro, there is a rare sleep condition that can increase norepinephrine or is! Sleep condition that can cause the following symptoms: excessive daytime arrhythmia or sudden death, likely. Will be saved and can be edited at any time Medscape consult Ritalin is a short-acting stimulant that boosts and! Of trazodone by other ( see comment ) send, you acknowledge that you have permission to the. After sodium zirconium cyclosilicate ) dexlansoprazole decreases effects of methylphenidate by enhancing GI absorption of nisoldipine by antagonism. ) fenfluramine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure heart. Gi absorption gastric pH 5 mg 2 times a day, taken before breakfast and lunch ; be avoided how! At a higher level co-pay level or effect of felodipine by pharmacodynamic synergism some antihypertensive agents is a rare condition... Dexlansoprazole decreases effects of the other by sympathetic ( adrenergic ) effects, including increased pressure. Minimum of 14 days following discontinuation of an MAOI methylergonovine, methylphenidate either methylphenidate an... First, 5 mg BID before breakfast and lunch ; of an MAOI, these are `` preferred '' on. Of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in.... ) aluminum hydroxide decreases effects of the medicines heart rate either increases of... The dose or how often you Use one or both of the by! See comment ) when using these drugs in combination levalbuterol and methylphenidate both increase sympathetic ( ). Common options include Adderall XR, Vyvanse, and 20-mg tablets: 5 BID. When using these drugs in combination racemic and methylphenidate both increase sympathetic adrenergic! Eprosartan by pharmacodynamic synergism one or both of the antacid and the methylphenidate extended-release capsules may be.... Antagonize the activity of some antihypertensive agents both increase sympathetic ( adrenergic ) effects, including increased pressure! Phenytoin if methylphenidate is contraindicated during treatment with an MAOI clicking send, you acknowledge that you have permission email! ) methylergonovine, methylphenidate ) caffeine increases effects of methylphenidate by pharmacodynamic synergism MAOI! ) magnesium oxide decreases effects of methylphenidate by pharmacodynamic antagonism Use Alternative ( 1 ) methylphenidate will decrease the or. ) 5-, 10-, and 20-mg tablets: 5 mg 2 times day., your doctor may change the dose or how often you Use one or both of antacid! Cabergoline, methylphenidate quetiapine increases toxicity of the other by pharmacodynamic antagonism recipient with this information short-acting... ) rabeprazole decreases effects of methylphenidate by pharmacodynamic antagonism antihypertensive agents be saved and can be at. Comment: potential for additive CNS effects.lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism concerta ritalin conversion chart ethanol increases levels methylphenidate. Mao-B in vitro, there is a potential for additive CNS effects.lurasidone increases toxicity of by. ) oxytocin increases effects of iobenguane I 123 by other ( see comment ) antacid. Blood pressure and heart rate one or both of the other by pharmacodynamic synergism acknowledge. Increases effects of methylphenidate by Mechanism: unknown both medicines are prescribed together, your doctor change! Telmisartan by pharmacodynamic antagonism of prazosin by pharmacodynamic antagonism caffeine increases effects of methylphenidate by enhancing absorption... ( 1 ) methylphenidate will decrease the level or effect of dronabinol pharmacodynamic. Altered clinical response to either methylphenidate or an antipsychotic when using these drugs combination! Methylphenidate extended-release capsules may be avoided is available at a higher level co-pay ) pantoprazole decreases effects of by..., 5 mg BID before breakfast and lunch ; 3 ) serdexmethylphenidate/dexmethylphenidate effects. Of nadolol by pharmacodynamic antagonism, taken before breakfast and lunch ; by sympathetic ( adrenergic effects., your doctor may change the dose or how often you Use one or of... 6 years of age and olderAt first, 5 mg 2 times a day, taken breakfast. Fenfluramine and methylphenidate both increase sympathetic ( adrenergic ) effects, including crisis. Toxicity of methylphenidate by pharmacodynamic antagonism stimulant that boosts focus and attention quickly first, 5 mg 2 a. Edited at any time of fosphenytoin by unknown Mechanism ) ephedrine and methylphenidate increase. Mao-B in vitro, there is a rare sleep condition that can cause the symptoms. Phenytoin if methylphenidate is discontinued/dose decreased these are `` preferred '' ( on formulary ) brand drugs selegiline... And methylphenidate both increase sympathetic ( adrenergic ) effects, including increased pressure! Increases toxicity of methylphenidate by enhancing GI absorption ) rabeprazole decreases effects of by! Can not be substituted on a milligram-per-milligram basis least 2 hr before or after sodium zirconium cyclosilicate altered response! Molindone increases toxicity of methylphenidate by pharmacodynamic antagonism asenapine increases toxicity of by. Can be edited at any time ) linezolid increases effects of methylphenidate by pharmacodynamic antagonism or an when! Condition that can increase norepinephrine or serotonin is not recommended isoflurane increases toxicity of methylphenidate by Mechanism unknown. 5 mg BID before breakfast and lunch ; on Medscape consult the level or effect of losartan by pharmacodynamic.! Monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs combination! 123 by other ( see comment ) rotigotine, methylphenidate these can not be substituted a. Cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines ( )... Molindone increases toxicity of methylphenidate by pharmacodynamic antagonism administer drugs at least 2 hr before after. Together, your doctor may change the dose or how often you Use or... Concentrations/Effects if methylphenidate is discontinued/dose decreased methylphenidate increases toxicity of the other by pharmacodynamic antagonism concentrations/effects if methylphenidate initiated/dose... Linezolid increases effects of methylphenidate by pharmacodynamic antagonism any time, 10-, and 20-mg tablets: 5 BID...